Cellular Biomedicine Group Inc (NASDAQ:CBMG)

18.60
Delayed Data
As of Apr 25
 -1.30 / -6.53%
Today’s Change
5.05
Today|||52-Week Range
22.75
+65.33%
Year-to-Date

Stock Price Forecast

The 1 analysts offering 12-month price forecasts for Cellular Biomedicine Group Inc have a median target of 32.00, with a high estimate of 32.00 and a low estimate of 32.00. The median estimate represents a +72.04% increase from the last price of 18.60.

Analyst Recommendations

The current consensus among 2 polled investment analysts is to Buy stock in Cellular Biomedicine Group Inc. This rating has held steady since April, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
--
Sales
-$32.8B
Reporting Date
May 07

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly --
 
 
 
 
Growthannually 2.62%
 
 
 
 

Sales

Growthquarterly --
 
 
 
 
 
Growthannually -39.14%
 
 
 
 
Key to the earnings and sales forecast charts.